Evexia Lifecare Ltd Stock Price Today (NSE: EVEXIA)

Evexia Lifecare Ltd

1.490.02 (1.32%)
Market Closed

Fundamental Score

...

Evexia Lifecare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Evexia Lifecare Ltd share price today is 1.49, down 1.32% on NSE/BSE as of 3 August 2026. Evexia Lifecare Ltd (EVEXIA) is a Small-cap company in the Trading - Chemicals sector with a market capitalisation of 300.38 (Cr). The 52-week high for EVEXIA share price is 2.42 and the 52-week low is 0.47. At a P/E ratio of 185.42x, EVEXIA is currently trading above its industry average P/E of 34.69x.

Evexia Lifecare Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
1.82
Low
1.45
Volume
51.4L
Change
-13.79%

Evexia Lifecare Ltd share price chart: -13.79% return over the past month. 52-week high ₹2.42, 52-week low ₹0.47.

Evexia Lifecare Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
1.511.521.451.5040.57L (Cr)
1.561.611.471.5176.04L (Cr)
1.551.591.531.5468.26L (Cr)
1.571.621.521.5521.11L (Cr)
1.601.611.561.5867.94L (Cr)
1.641.681.561.5942.10L (Cr)
1.661.671.611.6445.48L (Cr)
1.681.731.621.6762.43L (Cr)
1.621.661.521.6539.08L (Cr)
1.601.631.561.5942.51L (Cr)

Evexia Lifecare Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
1.631.821.451.50-7.98%
1.811.951.551.67-7.73%
1.071.871.051.86+73.83%
0.511.020.471.02+100.00%
1.481.650.530.53-64.19%
1.631.901.481.50-7.98%
1.641.801.561.62-1.22%
1.701.951.531.64-3.53%
1.821.851.521.67-8.24%
2.052.151.651.80-12.20%
2.262.382.052.05-9.29%
2.272.422.202.26-0.44%

Returns & Performance

Return on Equity (ROE)

N/A

Profit generated per ₹1 of shareholder equity

Return on Capital (ROCE)

N/A

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

2.37%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Evexia Lifecare Ltd Valuation Check

Poor

Price to Earnings (P/E)

185.42x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

34.69x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Poor

Promoter Holding

3.36%

% shares held by company founders/management

Poor

FII Holding

0.12%

% shares held by foreign institutional investors

Poor

DII Holding

0.09%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

151.61%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

55.82%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

0.68%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-16.41%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

4.34%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

2.16x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

221.00x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-25.77 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Evexia Lifecare Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of EVEXIA across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Robust Profit Growth (151.61%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (55.82%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Strong Interest Coverage (221.00x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

10 factors identified

Margin Pressure Concerns (2.37%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Premium Valuation Risk (P/E: 185.42x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Limited Growth History (0.68% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Earnings Growth (-16.41% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (4.34% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Elevated Debt Levels (D/E: 2.16)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Negative Free Cash Flow (₹-25.77 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (3.36%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

Limited Institutional Interest (FII+DII: 0.21%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Evexia Lifecare Ltd vs Trading - Chemicals Peers

Peer Comparison - Trading - Chemicals

Compare Evexia Lifecare Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
21.4/100
1
₹300.38
185.4
Average
2.2
Poor
4.34%
Average
0.68%
Average
0.00%
33.3/100
95
₹748.08
36.1
Average
0.80%
Poor
0.80%
Poor
0.0
Excellent
-2.80%
Poor
107.59%
Excellent
3.25%
38.6/100
242
₹458.99
36.5
Average
9.80%
Poor
14.86%
Average
0.0
Excellent
2.24%
Average
10.05%
Good
2.78%
16.9/100
30
₹298.03
34.7
Average
17.90%
Good
22.12%
Excellent
0.1
Excellent
0.00%
56/100
111
₹281.20
3.6
Average
20.93%
Excellent
15.30%
Good
1.7
Average
55.21%
Excellent
52.73%
Excellent
0.00%
A 1...
AIL542012
54.6/100
38
₹276.92
46.2
Average
11.55%
Average
11.66%
Average
0.8
Good
17.63%
Excellent
18.76%
Excellent
0.62%
63.1/100
37
₹252.97
18.8
Average
11.61%
Average
14.01%
Average
0.2
Excellent
12.07%
Good
21.22%
Excellent
0.13%
49.4/100
100
₹64.91
80.1
Average
0.36%
Poor
0.38%
Poor
0.0
Excellent
17.92%
Excellent
17.98%
Excellent
2.03%
37.4/100
54
₹53.94
26.7
Average
5.13%
Poor
6.44%
Poor
0.3
Excellent
1.23%
Average
20.59%
Excellent
0.00%
22.1/100
29
₹20.99
51.2
Average
0.64%
Poor
0.40%
Poor
0.0
Excellent
-29.53%
Poor
-21.71%
Poor
0.00%
32.4/100
16
₹11.15
11.2
Average
4.85%
Poor
7.18%
Poor
0.4
Excellent
35.37%
Excellent
-39.35%
Poor
0.00%

Evexia Lifecare Ltd PE Ratio History

Historical price-to-earnings ratio for EVEXIA — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20240.02₹3.45172.5x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Evexia Lifecare Ltd Quarterly Performance

Latest quarterly metrics for EVEXIA — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

55.82%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

151.61%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

0.68%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

4.34%

Compounded annual net profit growth over 5 years

Evexia Lifecare Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for EVEXIA — calculated from daily price history

35RSI 14
Neutral — RSI 35

Momentum is balanced — neither overbought nor oversold.

SMA 50
2
▼ Price below SMA 50 — Short-term bearish
SMA 200
2
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
5036K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Evexia Lifecare Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Evexia Lifecare Ltd (EVEXIA) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Evexia Lifecare Ltd

About EVEXIA (Evexia Lifecare Ltd)

Evexia Lifecare Ltd is a multifaceted entity operating within the dynamic landscape of chemical trading. Sourcing and distributing a diverse portfolio of chemical products, Evexia ...caters to a broad spectrum of industries, positioning itself as a key intermediary in the supply chain. Beyond basic chemical compounds, the company's inventory includes specialized chemicals tailored for pharmaceutical applications, demonstrating a commitment to serving critical sectors with high-quality materials. Evexia's operations are geared toward facilitating the efficient flow of essential chemicals, supporting manufacturing processes and contributing to the broader economic ecosystem through its trading activities. The company aims to provide reliable access to chemicals, addressing the nuanced needs of its clientele and fostering long-term partnerships based on trust and performance. The scope of Evexia Lifecare's commercial activities extends beyond the realm of chemicals, encompassing a range of products. This diversification strategically broadens the company's market presence and reduces its reliance on specific sectors. These include edible oils, which addresses essential food and beverage sector needs. The trade of diamonds and gold suggests a presence in the commodity and potentially the luxury goods markets, adding another dimension to Evexia's portfolio. Furthermore, the inclusion of plastic granules and lubricants illustrates a focus on providing raw materials for manufacturing and industrial applications, strengthening the company's connection to the production of various goods. Evexia's approach demonstrates an adaptable strategy of capturing opportunities across different markets. In addition to its chemical trading and diversified product portfolio, Evexia Lifecare engages in technology-driven services, including website, mobile application, and software development, offering a unique synergistic approach. This indicates a strategy to integrate technology into its core operations and possibly offer solutions to clients. The company also entered into the manufacturing of eBikes, demonstrating a commitment to sustainable transportation. This expansion shows a broader vision that incorporates technology and sustainable solutions, potentially leveraging these segments to enhance the overall value proposition. Through its diverse activities, Evexia Lifecare aims to establish itself as a comprehensive player in multiple domains, combining traditional trading with modern technological advancements.

Company Details

Symbol:EVEXIA
Industry:Trading - Chemicals
Sector:Trading - Chemicals

Key Leadership

Mr. Jayesh Raichandbhai Thakkar
MD & Chairman
Mr. Bhavesh Jayantibhai Desai
Chief Financial Officer

EVEXIA Share Price: Frequently Asked Questions

What is the current share price of Evexia Lifecare Ltd?

Evexia Lifecare Ltd (EVEXIA) trades at ₹1.49 on NSE and BSE. Market cap ₹300.38 (Cr). Educational data only.

What is the P/E ratio of Evexia Lifecare Ltd?

Evexia Lifecare Ltd has a P/E of 185.42x vs industry average 34.69x.

What is the Bull Run score for Evexia Lifecare Ltd?

Evexia Lifecare Ltd has a Bull Run score of 21.4/100 based on 25+ financial parameters.

Does Evexia Lifecare Ltd pay dividends?

Evexia Lifecare Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Evexia Lifecare Ltd?

Evexia Lifecare Ltd has ROE of N/A. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Evexia Lifecare Ltd?

Evexia Lifecare Ltd has debt-to-equity of 2.16.

Is Evexia Lifecare Ltd a good investment?

Bull Run gives Evexia Lifecare Ltd a score of 21.4/100. This is not investment advice — consult a SEBI-registered advisor.